CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology
CytRx Corporation (Nasdaq: CYTR) today announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent covering the tumor-targeting conjugate INNO-206 linker platform technology and INNO-206 pharmaceutical compositions.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.